Events & Presentations

Presentations
Date Title
April, 2017
Featured Events
Date Details Remind Me
May 2, 2017
8:30 AM ET
Concert Pharmaceuticals First Quarter 2017 Financial Results
Email

Concert Pharmaceuticals First Quarter 2017 Financial Results

Remind Me

Please sign up for Email alerts.


Upcoming Events
Date Details Remind Me
May 3, 2017
2:50 PM ET
Deutsche Bank Securities 42nd Annual Health Care Conference
Location: Boston, MA

This communication is being made in respect of the proposed asset sale with Vertex. The proposed asset sale and the asset purchase agreement will be submitted to the shareholders of the Company for their consideration and approval. In connection with the proposed asset sale, the Company will file a proxy statement with the SEC.  This communication does not constitute a solicitation of any vote or proxy from any shareholder of the Company. Investors are urged to read the proxy statement carefully and in its entirety when it becomes available and any other relevant documents or materials filed or to be filed with the SEC or incorporated by reference in the proxy statement, because they will contain important information about the proposed asset sale. The definitive proxy statement will be mailed to the Company's shareholders. In addition, the proxy statement and other documents will be available free of charge at the SEC's internet website, www.sec.gov. When available, the proxy statement and other pertinent documents may also be obtained free of charge at the Investors section the Company's website, www.concertpharma.com, or by directing a written request to Concert Pharmaceuticals, Inc., Attn: Investor Relations, at 99 Hayden Ave, #500, Lexington, MA 02421.

The Company and its directors, executive officers and other members of management and employees may be deemed to be participants in the solicitation of proxies in connection with the proposed asset sale. Information about the Company's directors and executive officers is included in the Company's Annual Report on Form 10-K for the year ended December 31, 2016 filed with the SEC on March 6, 2017. Additional information regarding these persons and their interests in the transaction will be included in the proxy statement relating to the proposed asset sale when it is filed with the SEC. These documents can be obtained free of charge from the sources indicated above.

Email

Deutsche Bank Securities 42nd Annual Health Care Conference

Remind Me

Please sign up for Email alerts.


May 22, 2017
1:30 PM ET
UBS Global Healthcare Conference
Location: New York City
Email

UBS Global Healthcare Conference

Remind Me

Please sign up for Email alerts.


Jun 6–9, 2017
Jefferies 2017 Global Healthcare Conference
Location: New York City
Email

Jefferies 2017 Global Healthcare Conference

Remind Me

Please sign up for Email alerts.


Jun 20–21, 2017
The JMP Securities Life Sciences Conference
Location: New York City
Email

The JMP Securities Life Sciences Conference

Remind Me

Please sign up for Email alerts.


Archived Events
Date Details
Mar 16, 2017
9:30 AM ET
Barclays Global Healthcare Conference
Location: Miami, FL
Mar 14, 2017
11:30 AM PT
29th Annual ROTH Conference
Location: Dana Point, CA
Mar 6, 2017
2:40 PM ET
Cowen and Company 37th Annual Health Care Conference
Location: Boston, MA
Mar 6, 2017
8:30 AM ET
Concert Pharmaceuticals Fourth Quarter 2016 Financial Results
= add file to Briefcase